High-Confidence Cancer Patient Stratification Through Multiomics Investigation of DNA Repair Disorders

November 2022 in “ Cell Death and Disease ”

Garik V. Mkrtchyan, Alexander Veviorskiy, Evgeny Izumchenko, Anastasia Shneyderman, Frank W. Pun, Ivan V. Ozerov, Alex Aliper, Alex Zhavoronkov, Morten Scheibye‐Knudsen

Studysummary In this study, the researchers identified CEP135 as a biomarker linked to poor sarcoma survival and suggested PLK1 as a potential therapeutic target for sarcoma patients with high CEP135 expression. Our plain-language summary of this paper — not a Tressless recommendation.

The study utilized the AI-driven PandaOmics platform to investigate gene expression changes in DNA repair-deficient disorders, identifying CEP135 as a potential biomarker for cancer patient stratification. High CEP135 expression was associated with poorer survival in sarcoma and glioma patients, suggesting its use as a prognostic biomarker. The study also identified polo-like kinase 1 (PLK1) as a promising therapeutic target for sarcoma patients with high CEP135 expression, as its inhibition significantly reduced cell growth in experimental models. The research highlighted the potential of AI-driven multiomics analysis for discovering novel cancer biomarkers and therapeutic targets, although further validation was needed.

View this study on nature.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Chemistry42: An AI-Driven Platform for Molecular Design and Optimization

180 citations , February 2023 in “Journal of Chemical Information and Modeling”

In this paper, Chemistry42—a software integrating AI with computational and medicinal chemistry—demonstrated efficiency in designing novel molecular structures targeting DDR1 and CDK20, with properties validated in both in vitro and in vivo studies.

An Analysis of Gene Expression Data Involving Examination of Signaling Pathways Activation Reveals New Insights into the Mechanism of Action of Minoxidil Topical Foam in Men with Androgenetic Alopecia

research An Analysis of Gene Expression Data Involving Examination of Signaling Pathways Activation Reveals New Insights into the Mechanism of Action of Minoxidil Topical Foam in Men with Androgenetic Alopecia

12 citations , June 2017 in “Cell Cycle”

This study observed that 5% minoxidil topical foam alters gene expression and signaling pathways in the scalp, providing insights into its mechanism of action in men with androgenetic alopecia.

Multicentric Parallel Phase II Trial of the Polo-Like Kinase 1 Inhibitor BI 2536 in Patients With Advanced Head and Neck Cancer, Breast Cancer, Ovarian Cancer, Soft Tissue Sarcoma, and Melanoma. The First Protocol of the European Organization for Research and Treatment of Cancer Network of Core Institutes

research Multicentric Parallel Phase II Trial of the Polo-Like Kinase 1 Inhibitor BI 2536 in Patients With Advanced Head and Neck Cancer, Breast Cancer, Ovarian Cancer, Soft Tissue Sarcoma, and Melanoma. The First Protocol of the European Organization for Research and Treatment of Cancer Network of Core Institutes

93 citations , May 2010 in “European Journal of Cancer”

This phase II trial found that BI 2536 demonstrated limited antitumor activity across five solid tumor types, with no confirmed objective responses observed.